학술논문
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial
Document Type
Article
Author
Source
In The Lancet Psychiatry March 2022 9(3):199-210
Subject
Language
ISSN
2215-0366